Cargando…
Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial
BACKGROUND: Magnesium salts bind dietary phosphorus, but their use in renal patients is limited due to their potential for causing side effects. The aim of this study was to evaluate the efficacy and safety of magnesium carbonate (MgCO(3)) as a phosphate-binder in hemodialysis patients. METHODS: For...
Autores principales: | Tzanakis, Ioannis P., Papadaki, Antonia N., Wei, Mingxin, Kagia, Stella, Spadidakis, Vlassios V., Kallivretakis, Nikolaos E., Oreopoulos, Dimitrios G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268719/ https://www.ncbi.nlm.nih.gov/pubmed/18193489 http://dx.doi.org/10.1007/s11255-007-9300-0 |
Ejemplares similares
-
Phosphate control in reducing FGF23 levels in hemodialysis patients
por: Rodelo-Haad, Cristian, et al.
Publicado: (2018) -
Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients
por: Farrand, Kimberly F, et al.
Publicado: (2014) -
Phosphate-control adherence in hemodialysis patients: current perspectives
por: Umeukeje, Ebele M, et al.
Publicado: (2018) -
Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial
por: Lim, Eunsoo, et al.
Publicado: (2018) -
A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis
por: Bhargava, Ramya, et al.
Publicado: (2019)